Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group and Specialty segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment provides pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. The Individual Commercial segment offers individual commercial fully-insured medical health insurance benefits under the HumanaOne brand. The company also provides closed-block long-term care insurance policies. As of December 31, 2017, it had approximately 14 million members in medical benefit plans, as well as approximately 7 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Industry, Sector and Symbol
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
Phone502-580-1000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$53.77 billion
Profitability
Miscellaneous
Employees45,900
OptionableOptionable
Humana (NYSE:HUM) Frequently Asked Questions
What is Humana's stock symbol?
Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."
How often does Humana pay dividends? What is the dividend yield for Humana?
Humana declared a quarterly dividend on Friday, November 2nd. Investors of record on Monday, December 31st will be paid a dividend of $0.50 per share on Friday, January 25th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date is Friday, December 28th. View Humana's Dividend History.
How will Humana's stock buyback program work?
Humana declared that its Board of Directors has approved a share buyback plan on Friday, December 15th 2017, which permits the company to buyback $3,000,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Shares buyback plans are generally an indication that the company's board believes its stock is undervalued.
How were Humana's earnings last quarter?
Humana Inc (NYSE:HUM) released its quarterly earnings data on Wednesday, November, 7th. The insurance provider reported $4.58 earnings per share for the quarter, topping the Zacks' consensus estimate of $4.29 by $0.29. The insurance provider had revenue of $14.21 billion for the quarter, compared to analyst estimates of $13.97 billion. Humana had a net margin of 2.70% and a return on equity of 19.10%. During the same quarter in the prior year, the company earned $3.39 earnings per share. View Humana's Earnings History.
When is Humana's next earnings date?
How can I listen to Humana's earnings call?
Humana will be holding an earnings conference call on Wednesday, February 6th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8886257430.
What guidance has Humana issued on next quarter's earnings?
Humana updated its FY18 earnings guidance on Wednesday, November, 28th. The company provided earnings per share guidance of $14.40 for the period, compared to the Thomson Reuters consensus estimate of $14.43.
What price target have analysts set for HUM?
18 brokerages have issued 12-month price objectives for Humana's stock. Their predictions range from $270.00 to $418.00. On average, they anticipate Humana's stock price to reach $349.89 in the next twelve months. This suggests a possible upside of 17.3% from the stock's current price. View Analyst Price Targets for Humana.
What is the consensus analysts' recommendation for Humana?
18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 4 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Humana.
What are Wall Street analysts saying about Humana stock?
Here are some recent quotes from research analysts about Humana stock:
- 1. Cantor Fitzgerald analysts commented, ". We reiterate our Neutral rating on HUM shares and maintain our 12-month price target of $325. After the market close on the company reaffirmed its 2018 EPS guidance. The company also provided updated 2019 membership metrics. Given the update, we are increasing our 2019 revenue and EPS estimates. The company had previously indicated that it expected 2019 adjusted EPS to grow above its stated long-term goal of 11-15%. With its filing on Wednesday, the company did not comment on 2019 EPS guidance, but will provide detailed 2019 financial guidance when it reports 4Q18 and year-end 2018 results on Wednesday, February 6, 2019." (1/2/2019)
- 2. According to Zacks Investment Research, "Humana’s shares have outperformed its industry’s growth in a year’s time. The insurer is well-poised for growth on the back of its strong Medicare business. Its top line has been witnessing an uptrend for the past several years. Sufficient generation of cash flow has helped the company take up many capital deployment initiatives aimed at enhancing its shareholder value. Acquisitions and dispositions made by the company have also led to business growth over the last few quarters. However, its rising level of expenses since 2010 persistently weighs on the bottom line. The company expects to witness rise in benefit expenses which will lead to an overall increase in operating expenses going forward." (12/31/2018)
Has Humana been receiving favorable news coverage?
Media stories about HUM stock have been trending negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Humana earned a news sentiment score of -2.1 on InfoTrie's scale. They also assigned news coverage about the insurance provider a news buzz of 6.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the stock's share price in the next few days.
Who are some of Humana's key competitors?
Who are Humana's key executives?
Humana's management team includes the folowing people:
- Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 57)
- Mr. Brian Andrew Kane, Sr. VP & CFO (Age 46)
- Mr. Christopher Mark Todoroff, Chief Legal Officer (Age 56)
- Mr. Timothy S. Huval, Chief HR Officer (Age 53)
- Ms. Jody L. Bilney, Chief Consumer Officer (Age 58)
Who are Humana's major shareholders?
Humana's stock is owned by a number of of institutional and retail investors. Top institutional investors include Bank of Montreal Can (0.24%), DNB Asset Management AS (0.06%), Strs Ohio (0.05%), Nisa Investment Advisors LLC (0.05%), Scout Investments Inc. (0.03%) and State of Alaska Department of Revenue (0.03%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.
Which institutional investors are selling Humana stock?
HUM stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Gulf International Bank UK Ltd, Meeder Asset Management Inc., Boston Advisors LLC, State of Alaska Department of Revenue, Highland Capital Management LLC, First Midwest Bank Trust Division and Strs Ohio. Company insiders that have sold Humana company stock in the last year include Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, Elizabeth D Bierbower, Heidi S Margulis, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley and William Kevin Fleming. View Insider Buying and Selling for Humana.
Which institutional investors are buying Humana stock?
HUM stock was acquired by a variety of institutional investors in the last quarter, including DNB Asset Management AS, MinichMacGregor Wealth Management LLC, Assenagon Asset Management S.A., Monument Capital Management, JGP Global Gestao de Recursos Ltda., QUANTRES ASSET MANAGEMENT Ltd, E&G Advisors LP and Nachman Norwood & Parrott Inc. View Insider Buying and Selling for Humana.
How do I buy shares of Humana?
Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Humana's stock price today?
One share of HUM stock can currently be purchased for approximately $298.19.
How big of a company is Humana?
Humana has a market capitalization of $40.91 billion and generates $53.77 billion in revenue each year. The insurance provider earns $2.45 billion in net income (profit) each year or $11.71 on an earnings per share basis. Humana employs 45,900 workers across the globe.
What is Humana's official website?
How can I contact Humana?
Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000 or via email at [email protected]
MarketBeat Community Rating for Humana (NYSE HUM)
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe HUM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HUM will underperform the S&P 500 over the long term. You may vote once every thirty days.
